Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Neurology | Family Medicine
Disease Category: Postherpetic Neuralgia
Location: United States, CO
New Investigational Medication for Postherpetic Neuralgia (PHN/Shingles)
This is a 12 week treatment study to evaluate the efficacy of two doses of new medication compared to placebo in lowering pain intensity in patients with PHN. There is also a 9 month follow - up period for a total duration of 12 months.
Patient Inclusion Criteria:
Patient Exclusion Criteria:
CW ID: 183365
Date Last Changed:
July 16, 2013
Alpine Clinical Research Center1000 Alpine Avenue, Suite 200Boulder, CO 80304Phone: 303-443-7229
Alpine Clinical Research Center
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.